Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026)
Earth Science Tech (ETST) posted Non Operating Investment Income of -$695051.0 for Q1 2026, down 13.25% on a QoQ basis from -$613741.0 in Q4 2025, and down 653.61% year-over-year from $125549.0 in Q1 2025.
Earth Science Tech (ETST) Non Operating Investment Income (2024 - 2026) Analysis & Trends
Earth Science Tech's Non Operating Investment Income history runs 3 years deep, the most recent figure standing at -$695051.0 for Q1 2026.
- Quarterly Non Operating Investment Income fell 653.61% year-over-year to -$695051.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (changed N/A YoY) and the FY2026 annual result came in at -$957118.0, down 418.87% from the prior year.
- Non Operating Investment Income was -$695051.0 for Q1 2026 at Earth Science Tech, down from -$613741.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $145558.0 in Q3 2025 and bottomed at -$695051.0 in Q1 2026.
- A 3-year average of -$192229.3 and a median of -$57845.5 in 2024 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2025 — Non Operating Investment Income tumbled 211.11% — and 2026, when it sank 653.61%.
- Earth Science Tech's Non Operating Investment Income stood at -$197277.0 in 2024, then tumbled by 211.11% to -$613741.0 in 2025, then declined by 13.25% to -$695051.0 in 2026.
- Business Quant data shows ETST's Non Operating Investment Income at -$695051.0 in Q1 2026, -$613741.0 in Q4 2025, and $145558.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Earth Science Tech | 32.24 Mn | 30.08 Mn | 6.27 Mn | -695,051.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -695,051.00 |
| Mar 31, 2026 | -695,051.00 |
| Dec 31, 2025 | -613,741.00 |
| Dec 31, 2025 | -613,741.00 |
| Sep 30, 2025 | 145,558.00 |
| Sep 30, 2025 | 145,558.00 |
| Jun 30, 2025 | 81,586.00 |
| Jun 30, 2025 | 81,586.00 |
| Mar 31, 2025 | 125,549.00 |
| Mar 31, 2025 | 125,549.00 |
| Dec 31, 2024 | -197,277.00 |
| Dec 31, 2024 | -197,277.00 |